Fideuram Intesa Sanpaolo Private Banking S.P.A. Takes Position in Cigna Group $CI

Fideuram Intesa Sanpaolo Private Banking S.P.A. purchased a new stake in shares of Cigna Group (NYSE:CI) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 12,005 shares of the health services provider’s stock, valued at approximately $3,304,000.

Other hedge funds also recently made changes to their positions in the company. Larson Financial Group LLC raised its holdings in Cigna Group by 39.7% during the fourth quarter. Larson Financial Group LLC now owns 4,068 shares of the health services provider’s stock worth $1,120,000 after purchasing an additional 1,157 shares in the last quarter. Aviance Capital Partners LLC raised its holdings in Cigna Group by 2.0% during the fourth quarter. Aviance Capital Partners LLC now owns 19,760 shares of the health services provider’s stock worth $5,438,000 after purchasing an additional 384 shares in the last quarter. Profund Advisors LLC raised its holdings in Cigna Group by 26.1% during the fourth quarter. Profund Advisors LLC now owns 4,345 shares of the health services provider’s stock worth $1,196,000 after purchasing an additional 900 shares in the last quarter. ProShare Advisors LLC raised its holdings in Cigna Group by 13.2% during the fourth quarter. ProShare Advisors LLC now owns 54,247 shares of the health services provider’s stock worth $14,930,000 after purchasing an additional 6,332 shares in the last quarter. Finally, Stronghold Wealth Management L.L.C. bought a new stake in Cigna Group during the fourth quarter worth approximately $258,000. Institutional investors own 86.99% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Robert W. Baird set a $337.00 target price on Cigna Group in a report on Friday, May 1st. Royal Bank Of Canada boosted their target price on Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a report on Friday, May 1st. Cantor Fitzgerald boosted their target price on Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a report on Friday, May 1st. Finally, UBS Group reissued a “buy” rating and set a $375.00 target price on shares of Cigna Group in a report on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and a consensus price target of $338.55.

Insiders Place Their Bets

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. The trade was a 85.46% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 205,904 shares of company stock worth $60,277,068. 0.60% of the stock is owned by insiders.

Cigna Group Trading Down 2.7%

Cigna Group stock opened at $283.36 on Thursday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The firm has a market cap of $74.96 billion, a price-to-earnings ratio of 12.01, a price-to-earnings-growth ratio of 1.02 and a beta of 0.30. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89. The firm’s 50 day moving average price is $275.73 and its two-hundred day moving average price is $275.77.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts predict that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a $1.56 dividend. The ex-dividend date is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is 26.45%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.